FABP4 and ovarian neoplasm: Nieman et al.,11 who studied ovarian tumour growth in FABP4−/− mice, attribute the decreased tumour burden solely to the lack of FABP4 expression in adipocytes and decreased FA metabolism in adjacent cancer cells.